| NCT Number | NCT07358858 |
| Lead Sponsor | Qilu Pharmaceutical Co., Ltd. |
| Conditions | Uncontrolled Hypertension |
| Enrollment | 12 participants |
| Start Date | 2026-01-23 |
| Primary Completion | 2026-02-07 (estimated) |
| Study Completion | 2026-02-07 (estimated) |
| Updated on ClinicalTrials.gov | 2026-01-22 |